Organization Profile

Cipher Pharmaceuticals Inc.

Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval...

You just read:

Cipher's partner launches Absorica™ (isotretinoin) capsules in U.S. market

News provided by

Cipher Pharmaceuticals Inc.

Nov 26, 2012, 08:30 ET